Revolution Medicines and Iambic Therapeutics announced a collaboration to develop targeted therapies for RAS-addicted cancers using AI discovery tools.
1 report, 1 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Revolution Medicines and Iambic Therapeutics announced a collaboration to develop targeted therapies for RAS-addicted cancers using AI discovery tools.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Revolution Medicines (United States)
company in Redwood City, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- GlobeNewswireRevolution Medicines and Iambic Announce Technology and Research Collaboration Using Iambic’s AI Discovery Tools to Pursue New Drug Candidates Custom-built model will be trained using Revolution Medi